Endometriosis Biomarker Detected by Next-Gen Tech
Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
Mirvie RNA Platform Predicts Severe Fetal Growth Restriction Months Before Birth
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Womens Health
Latest
New Stool Test and Therapy Show Promise for Endometriosis Diagnosis and Treatment
Researchers discovered a potential stool test and therapy for endometriosis, based on bacterial metabolites linked to the condition.
Home Test Reveals Risk of Heart Attack in Five Minutes
A new home-based questionnaire can identify individuals at high risk of heart attacks with the same accuracy as clinical blood tests.
Read More
Cell-Based Non-Invasive Prenatal Test Uses Simple Maternal Blood Draw
Menarini Silicon Biosystems presented a study, about its advanced non-invasive prenatal testing technology using maternal blood.
Read More
Blood Test Can Help Predict Risk of Sleep Apnea
Measuring blood levels of homocysteine can help predict the risk and progression of obstructive sleep apnea.
Read More
Better Congenital CMV Screening Needs More Awareness, Legislative Action
Recent advancements in congenital CMV (cCMV) screening underscore the need for enhanced awareness and legislative action.
Read More
New Test Rapidly Diagnoses Toxoplasma Infection
The test monitors pregnant women for Toxoplasma gondii infections, and detects infections within 30 minutes from a finger-prick.
Read More
Accounting for Self-Reported Race in Prenatal Screening Is Vital
Labs should consider self-reported race when screening for open neural tube defects to improve prenatal care equity for Black individuals.
Read More
First Trimester Screening Test Assesses Preeclampsia Risk
Labcorp has introduced a first trimester preeclampsia screening test to assess preeclampsia risk between 11- and 14-weeks’ gestation.
Read More
PinkDX to Develop Diagnostics that Address Women’s Unmet Medical Needs
PinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.Â
Read More
How New Machine Learning Models Can Help Diagnose Women’s Heart Disease
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read More
Making the Case for New Biomarker-based Assays
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read More
Agilent’s Postnatal Assay Gets European IVDR Class C Certification
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read More
Siemens’ New Reproductive Assay to Help Guide In Vitro Fertilization
The AMH Assay can support a lab’s reproductive endocrinology test menu as it aids a physician’s assessment of initiating IVF with a patient.
Read More
QuidelOrtho’s Triage Placental Growth Factor Test Approved for Labs Canada
The test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.Â
Read More
New Test Could Identify Aggressive Ovarian Cancers Early
A new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Read More
How Menstrual Blood Is Being Transformed Into a Diagnostic Tool
CLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read More